Subcutaneous Immunoglobulin Therapy Prevents Systemic Capillary Leak Syndrome Attack

Am J Med. 2016 Jul;129(7):e77-8. doi: 10.1016/j.amjmed.2016.02.046. Epub 2016 Apr 6.

Authors

Quentin Scanvion¹, Guillaume Lefèvre¹, Eric Hachulla¹, Pierre-Yves Hatron¹, Marc Lambert²

Affiliations

¹ University of Lille, Medical School Henri Warembourg, Internal Medicine Department, National Reference Center for Rare Autoimmune Systemic Diseases, FHU IMMINENT, CHRU, Lille, France.
² University of Lille, Medical School Henri Warembourg, Internal Medicine Department, National Reference Center for Rare Autoimmune Systemic Diseases, FHU IMMINENT, CHRU, Lille, France. Electronic address: marc.lambert@chru-lille.fr.

PMID: 27059380
DOI: 10.1016/j.amjmed.2016.02.046

No abstract available

Publication types

Case Reports
Letter

MeSH terms

Adult
Capillary Leak Syndrome / prevention & control*
Female
Humans
Immunization, Passive* / methods
Immunoglobulins / administration & dosage*
Injections, Subcutaneous

Substances

Immunoglobulins